Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer

被引：3

作者：

Anguiano, Ariel ^{[1
]}

Potti, Anil ^{[1
]}

机构：

[1] Duke Univ, Inst Genome Sci & Policy, Div Med Oncol, Durham, NC 27708 USA

来源：

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 2007年 / 7卷 / 06期

关键词：

cancer prognosis; cytotoxic chemotherapy; developmental therapeutics; genomic signatures; microarray; targeted therapy;

D O I：

10.1586/14737159.7.6.837

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Gene expression signatures have been developed in an effort to dissect the biologic phenotypes of malignancies. These signatures have tremendous power to identify new cancer subtypes and to predict clinical outcomes based on patterns of gene expression. Expression profiles specific to a phenotype can be derived from in vitro data, as well as from patient cohorts with clinically relevant outcomes. In addition to predicting outcomes in non-small-cell lung cancer (NSCLC), similar techniques have been used to develop gene expression signatures that predict sensitivity or resistance to specific chemotherapeutic agents. Additionally, expression data have been used to identify oncogenic pathway deregulation to help direct the use of targeted agents. Used in combination, it is likely that gene expression signatures will help assess prognosis and may also be of value in guiding the use of cytotoxic and targeted therapy in NSCLC. Clinical trials are ongoing to validate these predictive gene expression signatures in a prospective manner.

引用

页码：837 / 844

页数：8

共 44 条

[1] Genetic regulators of large-scale transcriptional signatures in cancer [J].

Adler, AS ;

Lin, MH ;

Horlings, H ;

Nuyten, DSA ;

van de Vijver, MJ ;

Chang, HY .

NATURE GENETICS, 2006, 38 (04) :421-430

[2] Gene-expression profiles predict survival of patients with lung adenocarcinoma [J].

Beer, DG ;

Kardia, SLR ;

Huang, CC ;

Giordano, TJ ;

Levin, AM ;

Misek, DE ;

Lin, L ;

Chen, GA ;

Gharib, TG ;

Thomas, DG ;

Lizyness, ML ;

Kuick, R ;

Hayasaka, S ;

Taylor, JMG ;

Iannettoni, MD ;

Orringer, MB ;

Hanash, S .

NATURE MEDICINE, 2002, 8 (08) :816-824

[3] Survival trees for analyzing clinical outcome in lung adenocarcinomas based on gene expression profiles:: Identification of neogenin and diacylglycerol kinase α expression as critical factors [J].

Berrar, D ;

Sturgeon, B ;

Bradbury, I ;

Downes, CS ;

Dubitzky, W .

JOURNAL OF COMPUTATIONAL BIOLOGY, 2005, 12 (05) :534-544

[4] Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].

Bhattacharjee, A ;

Richards, WG ;

Staunton, J ;

Li, C ;

Monti, S ;

Vasa, P ;

Ladd, C ;

Beheshti, J ;

Bueno, R ;

Gillette, M ;

Loda, M ;

Weber, G ;

Mark, EJ ;

Lander, ES ;

Wong, W ;

Johnson, BE ;

Golub, TR ;

Sugarbaker, DJ ;

Meyerson, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795

[5] Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].

Bild, AH ;

Yao, G ;

Chang, JT ;

Wang, QL ;

Potti, A ;

Chasse, D ;

Joshi, MB ;

Harpole, D ;

Lancaster, JM ;

Berchuck, A ;

Olson, JA ;

Marks, JR ;

Dressman, HK ;

West, M ;

Nevins, JR .

NATURE, 2006, 439 (7074) :353-357

[6] Linking oncogenic pathways with therapeutic opportunities [J].

Bild, Andrea H. ;

Potti, Anil ;

Nevins, Joseph R. .

NATURE REVIEWS CANCER, 2006, 6 (09) :735-U13

[7] Minimum information about a microarray experiment (MIAME) - toward standards for microarray data [J].

Brazma, A ;

Hingamp, P ;

Quackenbush, J ;

Sherlock, G ;

Spellman, P ;

Stoeckert, C ;

Aach, J ;

Ansorge, W ;

Ball, CA ;

Causton, HC ;

Gaasterland, T ;

Glenisson, P ;

Holstege, FCP ;

Kim, IF ;

Markowitz, V ;

Matese, JC ;

Parkinson, H ;

Robinson, A ;

Sarkans, U ;

Schulze-Kremer, S ;

Stewart, J ;

Taylor, R ;

Vilo, J ;

Vingron, M .

NATURE GENETICS, 2001, 29 (04) :365-371

[8] Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results [J].

Breathnach, OS ;

Freidlin, B ;

Conley, B ;

Green, MR ;

Johnson, DH ;

Gandara, DR ;

O'Connell, M ;

Shepherd, FA ;

Johnson, BE .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1734-1742

[9] Prognostic factors in non-small cell lung cancer - A decade of progress [J].

Brundage, MD ;

Davies, D ;

Mackillop, WJ .

CHEST, 2002, 122 (03) :1037-1057

[10] Protein profiles associated with survival in lung adenocarcinoma [J].

Chen, GA ;

Gharib, TG ;

Wang, H ;

Huang, CC ;

Kuick, R ;

Thomas, DG ;

Shedden, KA ;

Misek, DE ;

Taylor, JMG ;

Giordano, TJ ;

Kardia, SLR ;

Iannettoni, MD ;

Yee, J ;

Hogg, PJ ;

Orringer, MB ;

Hanash, SM ;

Beer, DG .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13537-13542

← 1 2 3 4 5 →